News & Notes
January 23, 2018

MedWiz 2.1 Launch at NYCQAL 2008

NEW YORK, October 30, 2008 - MedWiz Technologies is pleased to announce the launch of version 2.1 of their ePrescription and eMAR solution at the New York Coalition for Quality Assisted Living (NYCQAL) Annual Conference November 10-11, 2008 at the Turning Stone Resort and Casino in Verona, New York.

For more information about MedWiz Technologies, please visit: www.medwiztech.com

For more information about NYCQAL, please visit: www.nycqal.org

About MedWiz Technologies
MedWiz Technologies was founded in 2005 by pharmacy and long-term care industry leaders with the goal of dramatically improving patient safety and operational efficiency through powerful yet easy-to-use technology. MedWiz has offices in New York and Ohio. More information about MedWiz may be found online at: www.medwiztech.com

About ChemRx
Founded more than 40 years ago, ChemRx is a major institutional pharmacy serving the New York City metropolitan area, as well as parts of New Jersey, upstate New York, Pennsylvania and Florida. ChemRx’s client base includes skilled nursing facilities and a wide range of other long-term care facilities. ChemRx provides to more than 65,000 residents prescription and non-prescription drugs, intravenous medications, durable medical equipment items and surgical supplies. ChemRx’s website address is www.chemrx.net

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 about ChemRx Corporation. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are based upon the current beliefs and expectations of ChemRx’s management and are subject to risks and uncertainties that could cause actual results to differ from the forward-looking statements. The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: compliance with government regulations; changes in legislation or regulatory environments; requirements or changes adversely affecting the health care industry, including changes in Medicare reimbursement policies; fluctuations in customer demand; management of rapid growth; intensity of competition; timing, approval and market acceptance of new product introductions and institutional pharmacy locations; general economic conditions; geopolitical events and regulatory changes, as well as other relevant risks detailed in ChemRx Corporation’s filings with the SEC. The information set forth herein should be read in light of such risks. ChemRx Corporation does not assume any obligation to update the information contained in this press release.